Diabetic neuropathy is one of the most frequent and severe complications of diabetes mellitus. Although it accounts for considerable morbidity, increased risk of mortality, and reduced quality of life, diabetic neuropathy still remains inadequately diagnosed and treated in practice. For this reason, an international board of 15 neuropathy experts met for a virtual conference on the occasion of the World Diabetes Day 2020 to develop consensus recommendations and algorithms for screening, diagnosis, and management of diabetic neuropathy in clinical practice. These recommendations have been published in September 2021 in the journal “Diabetes Research and Clinical Practice”.(4)
On this website Wörwag Pharma provides information on the current consensus recommendations for health care professionals. Wörwag Pharma is globally committed to prevention, early detection, and therapy of diabetic neuropathy.